Читать книгу De PhD y otros demonios - Sandra Bermeo - Страница 177

1. Nime FA, Burek JD, Page DL, Holscher MA, Yardley JH. Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology. 1976 Apr;70(4):592-8.

2. Peng MM, Xiao L, Freeman AR, Arrowood MJ, Escalante AA, Weltman AC, et al. Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg Infect Dis. 1997 Oct-Dec;3(4):567-73.

3. Adl SM, Simpson AG, Lane CE, Lukeš J, Bass D, Bows-er SS, et al. The revised classification of eukaryotes. J Eukaryot Microbiol. 2012 Sep;59(5):429-93.

4. Chen XM, Keithly JS, Paya CV, LaRusso NF. Cryptosporidiosis. N Engl J Med. 2002 May 30;346(22):1723-31.

5. Xiao L, Fayer R, Ryan U, Upton SJ. Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev. 2004 Jan;17(1):72-97.

6. Tzipori S. Cryptosporidiosis in animals and humans. Microbiol Rev 1983; 47(1):84-96.

7. Genta RM, Chappell CL, White AC Jr, Kimball KT, Goodgame RW. Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis. Gastroenterology. 1993 Dec;105(6):1769-75.

8. Soto M, Velásquez G, Cuervo C, Galvis MT, Botero D. Criptosporidiosis respiratoria en un paciente con sida. Acta Med Colombia 1997;22:148-150.

9. Newman RD, Sears CL, Moore SR, Nataro JP, Wuhib T, Agnew DA, et al. Longitudinal study of Cryptosporidium infection in children in northeastern Brazil. J Infect Dis. 1999 Jul;180(1):167-75.

10. Okhuysen PC, Chappell CL, Sterling CR, Jakubowski W, DuPont HL. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun. 1998 Feb;66(2):441-3.

11. Benhamou Y, Kapel N, Hoang C, Matta H, Meillet D, Magne D, et al. Inefficacy of intestinal secretory immune response to Cryptosporidium in acquired immunodeficiency syndrome. Gastroenterology. 1995 Mar;108(3):627-35.

12. Crawford FG, Vermund SH, Ma JY, Deckelbaum RJ. Asymptomatic cryptosporidiosis in a New York City day care center. Pediatr Infect Dis J. 1988 Nov;7(11):806-7.

13. DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med. 1995 Mar 30;332(13):855-9.

14. Jokipii L, Jokipii AM. Timing of symptoms and oocyst excretion in human cryptosporidiosis. N Engl J Med. 1986 Dec 25;315(26):1643-7.

15. Clavel A, Arnal AC, Sánchez EC, Cuesta J, Letona S, Amiguet JA, et al. Respiratory cryptosporidiosis: case series and review of the literature. Infection. 1996 Sep-Oct;24(5):341-6.

16. Gross TL, Wheat J, Bartlett M, O’Connor KW. AIDS and multiple system involvement with Cryptosporidium. Am J Gastroenterol. 1986 Jun;81(6):456-8.

17. Houpt ER, Bushen OY, Sam NE, Kohli A, Asgharpour A, Ng CT, et al. Short report: asymptomatic Cryptosporidium hominis infection among human immunodeficiency virus-infected patients in Tanzania. Am J Trop Med Hyg. 2005 Sep;73(3):520-2.

18. Leitch GJ, He Q. Cryptosporidiosis-an overview. J Biomed Res. 2012 Jan;25(1):1-16.

19. Garcia LS, Bruckner DA, Brewer TC, Shimizu RY. Techniques for the recovery and identification of Cryptosporidium oocysts from stool specimens. J Clin Microbiol. 1983 Jul;18(1):185-90.

20. Parisi MT, Tierno PM Jr. Evaluation of new rapid commercial enzyme immunoassay for detection of Cryptosporidium oocysts in untreated stool specimens. J Clin Microbiol. 1995 Jul;33(7):1963-5.

21. Vieira-Silva C, Ferreira MS, Gonçalves-Pires MRF, Costa-Cruz JM. Detection of Cryptosporidium – specific coproantigen in human immunodeficiency virus/acquired immunodeficiency syndrome patients by using a commercially available immunoenzymatic assay. Mem Inst Oswaldo Cruz 2003; 98:1097-99.

22. Arrowood MJ, Sterling CR. Comparison of conventional staining methods and monoclonal antibody-based methods for Cryptosporidium oocyst detection. J Clin Microbiol. 1989 Jul;27(7):1490-5.

23. Taguchi T, Shinozaki Y, Takeyama H, Haraguchi S, Yoshino M, Kaneko M, et al. Direct counting of Cryptosporidium parvum oocysts using fluorescence in situ hybridization on a membrane filter. J Microbiol Methods. 2006 Nov;67(2):373-80.

24. Bueno-Franco RM. Branco N, Guiguet-Leal, DA. Parasitologia ambiental: Métodos de concentracao e deteccao de Cryptosporidum spp. E. Giardia spp. Em amostras de água. Ver Patol Trop 2012;41(2):119-135.

25. Morgan UM, Pallant L, Dwyer BW, Forbes DA, Rich G, Thompson RC. Comparison of PCR and microscopy for detection of Cryptosporidium parvum in human fecal specimens: clinical trial. J Clin Microbiol. 1998 Apr;36(4):995-8.

26. Amar CF, Dear PH, McLauchlin J. Detection and identification by real time PCR/RFLP analyses of Cryptosporidium species from human faeces. Lett Appl Microbiol. 2004;38(3):217-22.

27. Robinson G, Elwin K, Chalmers RM. Unusual Cryptosporidium genotypes in human cases of diarrhea. Emerg Infect Dis. 2008 Nov;14(11):1800-2.

28. Fayer R, Ungar BL. Cryptosporidium spp. and cryptosporidiosis. Microbiol Rev. 1986 Dec;50(4):458-83.

29. Lengerich EJ, Addiss DG, Marx JJ, Ungar BL, Juranek DD. Increased exposure to cryptosporidia among dairy farmers in Wisconsin. J Infect Dis. 1993 May;167(5):1252-5.

30. MacKenzie WR, Schell WL, Blair KA, Addiss DG, Peterson DE, Hoxie NJ, et al. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis. 1995 Jul;21(1):57-62.

31. Kuhls TL, Mosier DA, Crawford DL, Griffis J. Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence. Clin Infect Dis. 1994 May;18(5):731-5.

32. Perez-Schael I, Boher Y, Mata L, Perez M, Tapia FJ. Cryptosporidiosis in Venezuelan children with acute diarrhea. Am J Trop Med Hyg. 1985 Jul;34(4):721-2.

33. Esteban JG, Aguirre C, Flores A, Strauss W, Angles R, Mas-Coma S. High Cryptosporidium prevalences in health Aymara children from the Northern Bolivian Altiplano. Am J Trop Med Hyg 1998; 58(1):50-5.

34. Weikel CS, Johnston LI, De Sousa MA, Guerrant RL. Cryptosporidiosis in northeastern Brazil: association with sporadic diarrhea. J Infect Dis. 1985 May;151(5):963-5.

35. Blanco RA. Diarrea y Cryptosporidium en Guatemala. Bol Med Hosp. Infant Mex 1988; 45(3):139-43.

36. Carreño M, Velasco C, Rueda E. Prevalencia de Cryptosporidium spp. En niños menores de 13 años con afecciones oncológicas. Colombia Méd 2002;36(2) Supl 1:6-9.

37. Siuffi M, Angulo M, Velasco C, López P, Dueñas V, Rojas C. Relación entre los niveles de carga viral y los niveles de linfocitos CD4 en el diagnóstico de Cryptosporidium spp. en heces de niños de la Clínica pediátrica de VIH/SIDA del Hospital Universitario del Valle, Cali, Colombia. Colombia Méd 2006;37(1):15-20.

38. Angel VE, Franco L, Jaramillo JC, Medina LA, Ochoa FL, Vélez AM, et al. Cryptosporidiosis en Medellín. Prevalencia de Cryptosporidium en muestras fecales diarreicas en 6 laboratorios de Medellín. Estudio de 10 casos. Biomédica 1985:5:53-61.

39. Botero JH, Castaño A, Montoya MN, Ocampo NE, Hurtado MI, Lopera MM. A preliminary study of the prevalence of intestinal parasites in immunocompromised patients with and without gastrointestinal manifestations. Rev Inst Med Trop S Paulo 2003;45(4):197-200.

40. Navarro-Martínez L, da Silva AJ, Botero JH, Montoya MN, del Aguila C, Bornay-Linares FJ. Cryptosporidiosis in HIV-positive patients from Medellín, Colombia. J Eukaryot Microbiol 2006;53(Suppl 1):S37-9.

41. Nair P, Mohamed JA, DuPont HL, Figueroa JF, Carlin LG, Jiang ZD, et al. Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg. 2008 Aug;79(2):210-4.

42. Castillo R, Gilman R, Miranda E, Echeverria M, Lembcke J, Sterling C. Anticuerpos IgA secretorios de la leche materna preotectores contra la infección por Cryptosporidium parvum. Parasitol al Día 2001; 25:3-7.

43. Pelayo L, Nuñez FA, Rojas L, Wilke H, Furuseth Hansen E, Mulder B, et al. Molecular and epidemiological investigations of cryptosporidiosis in Cuban children. Ann Trop Med Parasitol. 2008 Dec;102(8):659-69.

44. Rossignol JF, Kabil SM, el-Gohary Y, Younis AM. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol. 2006 Mar;4(3):320-4.

45. Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis. 2005 Apr 15;40(8):1173-80.

46. Rossignol JF, Hidalgo H, Feregrino M, Higuera F, Gomez WH, Romero JL, et al. A double-’blind’ placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg. 1998 Nov-Dec;92(6):663-6.

47. Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002 Nov 2;360(9343):1375-80.

48. Botero D. Avances en el tratamiento de parasitosis intestinales. Biomédica 2007; 27 Supl 2:80-2.

49. White AC Jr, Chappell CL, Hayat CS, Kimball KT, Flanigan TP, Goodgame RW. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis. 1994 Aug;170(2):419-24.

50. Smith HV, Corcoran GD. New drugs and treatment for cryptosporidiosis. Curr Opin Infect Dis. 2004 Dec;17(6):557-64.

51. Carr A, Marriott D, Field A, Vasak E, Cooper DA. Treatment of VIH-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998; 351(9098):256-61.